The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate

doi:10.1084/jem.170.3.847

This Article

	Full Text (PDF, 1151K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Schroder, J. M.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Schroder, J. M.


Social Bookmarking

	What's this?

ARTICLES

The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate

JM Schroder
Department of Dermatology, University of Kiel, Federal Republic of Germany.

LPS and mitogen-stimulated mononuclear cells secrete a cytokine, which is able to activate the PMNL-arachidonate-5-lipoxygenase. This cytokine has been proven to be identical with the recently characterized novel neutrophil-activating peptide NAP/IL-8. NAP/IL-8 is able to activate human PMNL for release of LTB4, omega-oxidized LTB4, and 5-HETE in the presence of exogenous AA. Half-maximal concentration of NAP/IL-8 for release of LTB4 has been found to be near 4 x 10(-8) mol/liter. Time course studies revealed rapid activation of PMNL, with maximal release of LTB4 within the first 10 min with a decline up to 40 min. High amounts of omega-oxidized LTB4 were detected up to that time. Significant amounts of AA-5-LO-products can be detected only when PMNL were stimulated with NAP/IL-8 in the presence of exogenous AA. The concentration of AA necessary for half-maximal LTB4 release has been found to be 3 x 10(-6) mol/liter. In the presence of 8 x 10(-9) mol/liter [3H]AA, NAP/IL-8 (10(-9) to 10(-7) mol/liter) did not induce the production of LTB4, omega-oxidized LTB4, or 5-HETE. In addition, PMNL prelabeled with [3H]AA did not release either [3H]AA or 5- lipoxygenase metabolites when stimulated with NAP/IL-8 (10(-9) to 10(- 7) mol/liter), indicating that NAP/IL-8 apparently does not activate cellular phospholipases/diacylglycerol-lipases. Apart from FMLP, C5a, and PAF NAP/IL-8 is the fourth clearly characterized neutrophil chemotaxin able to activate the PMNL-5-lipoxygenase. The detection of large amounts of NAP/IL-8, arachidonic acid, as well as LTB4-like material, in lesional material of patients with psoriasis points towards a possibly important role of NAP/IL-8 in amplifying inflammatory processes by induction of LTB4-production.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Lappegard, K. T., Riesenfeld, J., Brekke, O.-L., Bergseth, G., Lambris, J. D., Mollnes, T. E. (2005). Differential Effect of Heparin Coating and Complement Inhibition on Artificial Surface-Induced Eicosanoid Production. Ann. Thorac. Surg. 79: 917-923 [Abstract] [Full Text]
Ahmad, A., Bayley, D. L., He, S., Stockley, R. A. (2003). Myeloid Related Protein-8/14 Stimulates Interleukin-8 Production in Airway Epithelial Cells. Am. J. Respir. Cell Mol. Bio. 29: 523-530 [Abstract] [Full Text]
Mukaida, N. (2003). Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am. J. Physiol. Lung Cell. Mol. Physiol. 284: L566-L577 [Abstract] [Full Text]
Podolin, P. L., Bolognese, B. J., Foley, J. J., Schmidt, D. B., Buckley, P. T., Widdowson, K. L., Jin, Q., White, J. R., Lee, J. M., Goodman, R. B., Hagen, T. R., Kajikawa, O., Marshall, L. A., Hay, D. W. P., Sarau, H. M. (2002). A Potent and Selective Nonpeptide Antagonist of CXCR2 Inhibits Acute and Chronic Models of Arthritis in the Rabbit. J. Immunol. 169: 6435-6444 [Abstract] [Full Text]
PETERS-GOLDEN, M., BAILIE, M., MARSHALL, T., WILKE, C., PHAN, S. H., TOEWS, G. B., MOORE, B. B. (2002). Protection from Pulmonary Fibrosis in Leukotriene-Deficient Mice. Am. J. Respir. Crit. Care Med. 165: 229-235 [Abstract] [Full Text]
Eberhard, J., Jepsen, S., Pohl, L., Albers, H. K., Acil, Y. (2002). Bacterial Challenge Stimulates Formation of Arachidonic Acid Metabolites by Human Keratinocytes and Neutrophils In Vitro. CVI 9: 132-137 [Abstract] [Full Text]
Malazdrewich, C., Ames, T. R., Abrahamsen, M. S., Maheswaran, S. K. (2001). Pulmonary Expression of Tumor Necrosis Factor Alpha, Interleukin-1 Beta, and Interleukin-8 in the Acute Phase of Bovine Pneumonic Pasteurellosis. Vet Pathol 38: 297-310 [Abstract] [Full Text]
Leland Booth, J., Metcalf, J. P. (1999). Type-Specific Induction of Interleukin-8 by Adenovirus. Am. J. Respir. Cell Mol. Bio. 21: 521-527 [Abstract] [Full Text]
Marleau, S., Fruteau de Laclos, B., Sanchez, A. B., Poubelle, P. E., Borgeat, P. (1999). Role of 5-Lipoxygenase Products in the Local Accumulation of Neutrophils in Dermal Inflammation in the Rabbit. J. Immunol. 163: 3449-3458 [Abstract] [Full Text]
Chung, K F, Barnes, P J (1999). Cytokines in asthma. Thorax 54: 825-857 [Full Text]
Zidovetzki, R., Chen, P., Chen, M., Hofman, F.M. (1999). Endothelin-1-Induced Interleukin-8 Production in Human Brain-Derived Endothelial Cells Is Mediated by the Protein Kinase C and Protein Tyrosine Kinase Pathways. Blood 94: 1291-1299 [Abstract] [Full Text]
Barnes, P. J., Chung, K. F., Page, C. P. (1998). Inflammatory Mediators of Asthma: An Update. Pharmacol. Rev. 50: 515-596 [Abstract] [Full Text]
Weinberg, A., Krisanaprakornkit, S., Dale, B.A. (1998). Epithelial Antimicrobial Peptides: Review and Significance for Oral Applications. CROBM 9: 399-414 [Abstract] [Full Text]
Allbert, J. R., Naef, R. W., Perry, K. G., Magann, E. F., Whitworth, N. S., Morrison, J. C. (1994). Amniotic Fluid Interleukin-6 and Interleukin-8 Levels Predict the Success of Tocolysis in Patients With Preterm Labor. Reproductive Sciences 1: 264-268 [Abstract]